145 related articles for article (PubMed ID: 35621105)
1. [KLF6 Super-enhancer Regulates Cell Proliferation by Recruiting GATA2 and SOX10 in Human Hepatoma Cells].
Ri KC; Ryong Ri M; Hun Kim K; Choe SI; Ri JH; Kim JH; Ri JH
Mol Biol (Mosk); 2022; 56(3):498-499. PubMed ID: 35621105
[TBL] [Abstract][Full Text] [Related]
2. The
Ri K; Kim C; Pak C; Ri P; Om H
Microrna; 2020; 9(1):64-69. PubMed ID: 30868974
[TBL] [Abstract][Full Text] [Related]
3. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
[TBL] [Abstract][Full Text] [Related]
4. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
[TBL] [Abstract][Full Text] [Related]
5. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
[TBL] [Abstract][Full Text] [Related]
6. GATA2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super-enhancers.
Li Y; Gao J; Kamran M; Harmacek L; Danhorn T; Leach SM; O'Connor BP; Hagman JR; Huang H
Nat Commun; 2021 Jan; 12(1):494. PubMed ID: 33479210
[TBL] [Abstract][Full Text] [Related]
7. Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma.
Kong LM; Yao L; Lu N; Dong YL; Zhang J; Wang YQ; Liu L; Zhang HL; Huang JG; Liao CG
Oncotarget; 2016 May; 7(19):27975-87. PubMed ID: 27057625
[TBL] [Abstract][Full Text] [Related]
8. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
9. Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6.
He AD; Xie W; Song W; Ma YY; Liu G; Liang ML; Da XW; Yao GQ; Zhang BX; Gao CJ; Xiang JZ; Ming ZY
Sci Rep; 2017 Jun; 7(1):3989. PubMed ID: 28638139
[TBL] [Abstract][Full Text] [Related]
10. The Krüppel-like factor 6 represses proliferation and invasion of cutaneous malignant melanoma.
Li YY; Zheng QM; Zhang N; Zhang M
Pol J Pathol; 2023; 74(3):194-202. PubMed ID: 37955538
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
12. [Mutations of the tumor suppressor Kruppel-like factor 6 (KLF6) gene in hepatocellular carcinoma and its effect of growth suppression on human hepatocellular carcinoma cell line HepG2].
Pan XC; Chen Z; Chen F; Chen XH; Zhou C; Yang ZG
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):109-13. PubMed ID: 16494780
[TBL] [Abstract][Full Text] [Related]
13. EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2.
Cui S; Wu Q; Liu M; Su M; Liu S; Shao L; Han X; He H
Cell Death Dis; 2021 Mar; 12(3):264. PubMed ID: 33712565
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene.
Lee UE; Ghiassi-Nejad Z; Paris AJ; Yea S; Narla G; Walsh M; Friedman SL
FEBS Lett; 2010 Mar; 584(5):1006-10. PubMed ID: 20116377
[TBL] [Abstract][Full Text] [Related]
15. MiR-200c-3p aggravates gastric cell carcinoma via KLF6.
Wang Y; Lu K; Li W; Wang Z; Ding J; Zhu Z; Li Z
Genes Genomics; 2021 Nov; 43(11):1307-1316. PubMed ID: 34524611
[TBL] [Abstract][Full Text] [Related]
16. Frequent down-regulation and deletion of KLF6 in primary hepatocellular carcinoma.
Wang S; Kang L; Chen X; Zhou H
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):470-6. PubMed ID: 20714872
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-like factor 6-mediated loss of BCAA catabolism contributes to kidney injury in mice and humans.
Piret SE; Guo Y; Attallah AA; Horne SJ; Zollman A; Owusu D; Henein J; Sidorenko VS; Revelo MP; Hato T; Ma'ayan A; He JC; Mallipattu SK
Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34074766
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
19. Expression of KLF6-SV2 in colorectal cancer and its impact on proliferation and apoptosis.
Zhang B; Guo DD; Zheng JY; Wu YA
Eur J Cancer Prev; 2018 Jan; 27(1):20-26. PubMed ID: 29084019
[TBL] [Abstract][Full Text] [Related]
20. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
